| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $79.9M | -1.5% |
| Cost of Revenue | $11.6M | -2.5% |
| Gross Profit | $68.3M | -1.3% |
| R&D Expense | $18.0M | +2.5% |
| SG&A Expense | $100.8M | -7.4% |
| Operating Income | -$50.5M | +11.8% |
| Interest Expense | $4.7M | -13.8% |
| Pre-tax Income | -$51.3M | +7.5% |
| Income Tax | $236K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.4M | -12.9% |
| Accounts Receivable | $10.8M | -24.5% |
| Inventory | $6.3M | -19.4% |
| Current Assets | $139.8M | -14.2% |
| Total Assets | $142.8M | -14.3% |
| Current Liabilities | $15.5M | +26.2% |
| Long-term Debt | $40.0M | +14.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.4M | +52.6% |
| Capital Expenditures | $385K | -51.3% |
| Investing Cash Flow | -$385K | +51.3% |
| Financing Cash Flow | $5.0M | +349.6% |
| Free Cash Flow | -$22.7M | +52.6% |
| +114.5% |
| Net Income | -$51.5M | +7.3% |
| EPS (Basic) | -$1.03 | +9.6% |
| EPS (Diluted) | -$1.03 | +9.6% |
| Total Liabilities |
| $55.3M |
| +19.1% |
| Stockholders' Equity | $87.5M | -27.2% |